Warren Jackman to Anti-Arrhythmia Agents
This is a "connection" page, showing publications Warren Jackman has written about Anti-Arrhythmia Agents.
Connection Strength
0.515
-
Pharmacological prevention and termination of focal atrial fibrillation. Europace. 2012 Mar; 14(3):426-30.
Score: 0.093
-
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011 Mar 15; 123(10):e269-367.
Score: 0.090
-
Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia. Am J Cardiol. 1988 Dec 20; 62(19):8L-19L.
Score: 0.077
-
Direct endocardial recording from an accessory atrioventricular pathway: localization of the site of block, effect of antiarrhythmic drugs, and attempt at nonsurgical ablation. Circulation. 1983 Nov; 68(5):906-16.
Score: 0.054
-
Electrophysiology of oral encainide. Am J Cardiol. 1982 Apr 01; 49(5):1270-8.
Score: 0.048
-
Non-pharmacological, non-ablative approaches for the treatment of atrial fibrillation: experimental evidence and potential clinical implications. J Cardiovasc Transl Res. 2011 Feb; 4(1):35-41.
Score: 0.022
-
An acute experimental model demonstrating 2 different forms of sustained atrial tachyarrhythmias. Circ Arrhythm Electrophysiol. 2009 Aug; 2(4):384-92.
Score: 0.020
-
Efficacy and electrophysiologic effects of encainide for atrioventricular nodal reentrant tachycardia. Am J Cardiol. 1988 Dec 20; 62(19):31L-36L.
Score: 0.019
-
The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis. 1988 Sep-Oct; 31(2):115-72.
Score: 0.019
-
Antifibrillatory actions of cisatracurium: an atrial specific M2 receptor antagonist. J Cardiovasc Electrophysiol. 2008 Aug; 19(8):861-8.
Score: 0.018
-
HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2007 Jun; 4(6):816-61.
Score: 0.017
-
Ventricular tachyarrhythmias in the long QT syndromes. Med Clin North Am. 1984 Sep; 68(5):1079-109.
Score: 0.014
-
Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms. Am Heart J. 1982 Feb; 103(2):177-84.
Score: 0.012
-
The monophasic action potential in clinical cardiology. Clin Cardiol. 1991 Jun; 14(6):505-10.
Score: 0.006
-
Role of electrophysiologic testing in managing patients who have ventricular tachycardia unrelated to coronary artery disease. Am J Cardiol. 1982 Jul; 50(1):165-71.
Score: 0.003
-
Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode. Am Heart J. 1982 May; 103(5):789-94.
Score: 0.003